Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial - Poll - MDSpire

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial

  • By

  • Oded Icht

  • Alexander Sun

  • Philip Wong

  • Andrew McPartlin

  • Thiago Pimentel Muniz

  • Anna Spreafico

  • Samuel D. Saibil

  • J. Nicholas Lukens

  • Sana D Karam

  • John De Almeida

  • Marcus O. Butler

  • C. Jillian Tsai

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial

  • by Oded Icht, Alexander Sun, Philip Wong, Andrew McPartlin, Thiago Pimentel Muniz, Anna Spreafico, Samuel D. Saibil, J. Nicholas Lukens, Sana D Karam, John De Almeida, Marcus O. Butler, C. Jillian Tsai

  • July 6, 2026

Related Content

Locus-specific HERV expression identifies an aggressive, NK-depleted, checkpoint-refractory acral melanoma phenotype

Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study

Artificial intelligence in three-dimensional total-body photography for skin cancer surveillance